Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Also see our Top Picks among products in this category
Using our expertise in anti-drug antibody generation we have developed a range of antibodies targeted against marketed biotherapeutic drugs to support clinical patient monitoring and biosimilar development
PILLAR works with over 200 professional teams worldwide
Key Industry Developments In March 2026 , China approved Pfizers once-weekly injectable GLP-1 weight-loss drug Xianweiying (ecnoglutide) for long-term weight management in overweight or obese adults, strengthening Pfizers position in the rapidly expanding obesity therapeutics market
US$ 21.20
US$ 28.35
US$ 22.72
US$ 25.84
US$ 28.67
